Annovis Bio, Inc. (ANVS)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Annovis Bio, Inc. reported revenue of $0. The company ran a net loss. It held $21.08M in total assets against $4.23M in total liabilities.
Key ratios (FY2025)
-171.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
| Operating Income | -$29.70M | -$26.69M | -$45.04M | -$25.51M | -$14.54M | -$6.64M | -$1.61M | — |
| Net Income | -$28.85M | -$24.59M | -$56.20M | -$25.33M | -$14.49M | -$5.46M | -$991.0K | — |
| EPS (Diluted) | $-1.40 | $-2.31 | $-6.23 | $-3.10 | $-1.90 | $-0.87 | — | — |
| Total Assets | $21.08M | $13.93M | $10.21M | $36.02M | $46.00M | $8.12M | $1.12M | — |
| Total Liabilities | $4.23M | $4.62M | $17.96M | $7.70M | $1.51M | $578.4K | $2.62M | — |
| Shareholders' Equity | $16.85M | $9.31M | -$7.75M | $28.32M | $44.49M | $7.54M | -$8.58M | -$7.59M |
| Cash & Equivalents | $19.53M | $10.55M | $5.75M | $28.38M | $45.69M | $8.07M | $1.9K | — |
| Operating Cash Flow | -$25.62M | -$21.89M | -$39.97M | -$17.31M | -$9.13M | -$3.97M | -$476.5K | — |
| Shares Outstanding | 27.20M | 14.14M | 10.52M | 8.16M | 8.10M | 6.89M | 282.6K | — |